全文获取类型
收费全文 | 1251篇 |
免费 | 91篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 96篇 |
妇产科学 | 43篇 |
基础医学 | 125篇 |
口腔科学 | 41篇 |
临床医学 | 179篇 |
内科学 | 242篇 |
皮肤病学 | 14篇 |
神经病学 | 55篇 |
特种医学 | 246篇 |
外科学 | 96篇 |
综合类 | 21篇 |
预防医学 | 36篇 |
眼科学 | 10篇 |
药学 | 56篇 |
中国医学 | 5篇 |
肿瘤学 | 81篇 |
出版年
2024年 | 3篇 |
2023年 | 9篇 |
2022年 | 3篇 |
2021年 | 10篇 |
2020年 | 10篇 |
2019年 | 9篇 |
2018年 | 28篇 |
2017年 | 12篇 |
2016年 | 25篇 |
2015年 | 22篇 |
2014年 | 34篇 |
2013年 | 33篇 |
2012年 | 40篇 |
2011年 | 33篇 |
2010年 | 43篇 |
2009年 | 64篇 |
2008年 | 43篇 |
2007年 | 21篇 |
2006年 | 25篇 |
2005年 | 22篇 |
2004年 | 16篇 |
2003年 | 26篇 |
2002年 | 27篇 |
2001年 | 30篇 |
2000年 | 20篇 |
1999年 | 21篇 |
1998年 | 51篇 |
1997年 | 55篇 |
1996年 | 67篇 |
1995年 | 50篇 |
1994年 | 44篇 |
1993年 | 47篇 |
1992年 | 20篇 |
1991年 | 19篇 |
1990年 | 18篇 |
1989年 | 44篇 |
1988年 | 35篇 |
1987年 | 40篇 |
1986年 | 43篇 |
1985年 | 29篇 |
1984年 | 26篇 |
1983年 | 17篇 |
1982年 | 25篇 |
1981年 | 14篇 |
1980年 | 11篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 18篇 |
1976年 | 13篇 |
1975年 | 15篇 |
排序方式: 共有1349条查询结果,搜索用时 0 毫秒
1.
2.
Gene amplification is an important mechanism of increased gene expression in a number of human solid tumors. We have recently identified and cloned sequences from a novel DNA amplification unit in malignant fibrous histiocytoma. The amplified sequences are derived from chromosome 12q13-14 and encode a gene designated SAS (sarcoma amplified sequence). In the present study, a series of soft tissue sarcomas was studied to characterize further the phenomenon of SAS amplification. Seven of 22 (32%) malignant fibrous histiocytomas and three liposarcomas contained SAS amplification. Strikingly, all of the tumors with SAS amplification occurred in central sites (i.e., in the abdominal or inguinal regions) rather than in the extremities (i.e., in the arms of legs). These observations demonstrate that SAS amplification occurs with a significant frequency in mesenchymal tumors and is particularly associated with abdominal disease. 相似文献
3.
Cerebellar toxicity with high-dose cytosine arabinoside 总被引:1,自引:0,他引:1
R H Herzig J D Hines G P Herzig S N Wolff P A Cassileth H M Lazarus D J Adelstein R A Brown P F Coccia S Strandjord 《Journal of clinical oncology》1987,5(6):927-932
CNS dysfunction, especially impaired cerebellar function, is the dose-limiting toxicity associated with high-dose cytosine arabinoside, which precludes doses of greater than 48 g/m2. Four hundred eighteen patients between the ages of 2 and 74 years with leukemia or lymphoma received 36 to 48 g/m2 cytosine arabinoside either alone or with anthracycline antibiotics, 4'-(9-acridinylamino) methane sulfon-m-anisidine (m-AMSA), or total body irradiation. In only 35 of 418 patients (8%) did severe cerebellar toxicity develop; it was irreversible or fatal in four (1%) patients. The age of the patient was a critical factor in the incidence of severe cerebellar toxicity. Patients greater than 50 years old had a statistically significant greater incidence of cerebellar toxicity compared with younger patients (26/137, 19%, v 9/281, 3%; P less than .0005, chi 2). Neither the diagnosis, disease status, sex, nor the regimen altered the incidence of severe cerebellar toxicity (when corrected for age). A second course of high-dose cytosine arabinoside, administered to 62 patients, did not increase the incidence of severe cerebellar toxicity, which occurred in five (8%) of these patients. Two of the five patients had severe toxicity with the initial course. Of the 60 patients with no antecedent cerebellar dysfunction, three (5%) had severe toxicity with the second course: one of 41 patients were less than 50 years old; two of 19 patients were greater than or equal to 50 years. Since the occurrence of severe cerebellar dysfunction is greatly affected by age, reduced doses of high-dose cytosine arabinoside should be given to patients greater than 50 years old, and methods for reducing the cerebellar toxicity should be investigated in these patients. 相似文献
4.
5.
B G Gordon K L Saving J A McCallister P I Warkentin J R McConnell W M Roberts P F Coccia W D Haire 《Bone marrow transplantation》1991,8(4):323-325
Hypercoagulable states associated with deficiencies in circulating anticoagulant protein C occur after chemotherapy for a variety of malignant diseases. Protein C deficiency also occurs following bone marrow transplantation (BMT) and may be responsible for a variety of transplantation-associated complications. We report the case of a child who suffered a stroke associated with low protein C antigen and activity occurring 11 months after allogeneic BMT. Protein C levels recovered spontaneously by 18 months after BMT. We speculate that the protein C deficiency and and resultant hypercoagulable state led to the stroke, and the deficiency of this anticoagulant was a sequela of the transplant. 相似文献
6.
Does altered biomechanics cause marrow edema? 总被引:21,自引:0,他引:21
7.
8.
9.
Carol Smillie B.N. B.Ed. M.S.C. Katherine Coffin B.A. ME.D. Kathryn Porter B.A. Brenda Ryan B.A. M.B.A. 《Journal of community health》1988,13(3):156-170
The International Conference on Primary Health Care, meeting in Alma-Ata, in the Soviet Union, September 12, 1978, expressed the need for urgent action by all governments, all health and development workers and the world community, to protect and promote the health of all people of the world. The world was caught by the phrase which emerged from this conference, Health For All by the Year 2000 and many have examined the articles of the Alma-Ata declaration and tried to implement them in their corner of the world. This paper describes a community-based smoking-cessation program which was implemented in the province of Nova Scotia, Canada, during the years 1980–1984. Primary to this project was the belief that people have the right and the duty to participate individually and collectively in planning and implementing their health care. This paper describes one community's effort in putting this belief into practice.Carol Smillie, B.N. BE.d. M.S.c. is an Assistant Professor at the School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada B3H 3J5, Katherine Coffin, BA, MEd is the Program Officer, Nova Scotia Office, Health Promotion Directorate Health and Welfare Canada, 5251 Duke Street, Halifax, Nova Scotia. Canada B3J 1P3. Kathryn Porter, B.A. (Gen)., is the Information and Education Coordinator, Nova Scotia Division Canadian Cancer Society. Brenda Ryan, B.A., M.B.A. is Program Evaluation Analysist, Nova Scotia Department of Health, 6088 Hollis Street, Halifax. Nova Scotia, Canada. This Project was funded by Health and Welfare Canada, Nova Scotia Department of Health, Nova Scotia Division Canadian Cancer Society, Requests for reprints should be addressed to: Professor Carol Smillie. 相似文献
10.
Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability 总被引:1,自引:15,他引:1
La Spada AR; Peterson KR; Meadows SA; McClain ME; Jeng G; Chmelar RS; Haugen HA; Chen K; Singer MJ; Moore D; Trask BJ; Fischbeck KH; Clegg CH; McKnight GS 《Human molecular genetics》1998,7(6):959-967
X-linked spinal and bulbar muscular atrophy (SBMA) is caused by a CAG
repeat expansion in the first exon of the androgen receptor (AR) gene.
Disease-associated alleles (37-66 CAGs) change in length when transmitted
from parents to offspring, with a significantly greater tendency to shift
size when inherited paternally. As transgenic mice carrying human AR cDNAs
with 45 and 66 CAG repeats do not display repeat instability, we attempted
to model trinucleotide repeat instability by generating transgenic mice
with yeast artificial chromosomes (YACs) carrying AR CAG repeat expansions
in their genomic context. Studies of independent lines of AR YAC transgenic
mice with CAG 45 alleles reveal intergenerational instability at an overall
rate of approximately 10%. We also find that the 45 CAG repeat tracts are
significantly more unstable with maternal transmission and as the
transmitting mother ages. Of all the CAG/CTG repeat transgenic mice
produced to date the AR YAC CAG 45 mice are unstable with the smallest
trinucleotide repeat mutations, suggesting that the length threshold for
repeat instability in the mouse may be lowered by including the appropriate
flanking human DNA sequences. By sequence-tagged site content analysis and
long range mapping we determined that one unstable transgenic line has
integrated an approximately 70 kb segment of the AR locus due to
fragmentation of the AR YAC. Identification of the cis - acting elements
that permit CAG tract instability and the trans -acting factors that
modulate repeat instability in the AR YAC CAG 45 mice may provide insights
into the molecular basis of trinucleotide repeat instability in humans.
相似文献